Singularity Future Technology Ltd. Filing Discloses On Aug. 9, Yang Jie Tendered Resignation From CEO Position

 On August 9, 2022, Mr. Yang Jie tendered his resignation from his positions as the Chief Executive Officer (“CEO”) and director of Singularity Future Technology Ltd. (the “Company”) to the

 On August 9, 2022, Mr. Yang Jie tendered his resignation from his positions as the Chief Executive Officer (“CEO”) and director of Singularity Future Technology Ltd. (the “Company”) to the board of directors of the Company (the “Board”), following the Board’s decision on August 8, 2022, which adopted the Special Committee’s recommendation that Mr. Jie be suspended immediately as the Company’s CEO, pending the Special Committee’s further investigation into allegations raised in the report of Hindenburg Research dated May 5, 2022 and other related matters. 

 

Total
0
Shares
Related Posts
Read More

Abbott Announced Data at the American Diabetes Association Scientific Sessions Show Freestyle Libre 3 System Is First and Only 14-day Continuous Glucose Monitor System to Achieve a Mean Absolute Relative Difference of Less Than 8%

Abbott (NYSE: ABT) today announced late-breaking clinical data that demonstrate the FreeStyle Libre® 3 system has an overall mean absolute relative difference (MARD) of 7.9%,1 making it the first and only 14-day continuous glucose monitoring (CGM) system to achieve a sub-8% overall MARD.

ABT